Richard van der Mast – Research output — Amsterdam UMC research portal

Research activity per year

4 Article
2 Abstract

6 results

2023

Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity
van Delft, M. A. M., Aleyd, E., Mast, R. V. D., de Jong, N., Boon, L., Simons, P. J. & van Egmond, M., 2023, In: Frontiers in immunology. 14, p. 1118539 1118539.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
IgA blocking FcαR1 (CD89) antibodies to treat IgA-mediated tissue damage in chronic inflammation and autoimmunity
van Delft - Soffers, M. A. M., Aleyd, E., van der Mast, R., van Egmond, M., Boon, L. & Simons, P. J., 2023.
Research output: Contribution to conference › Abstract › Academic
2022

Blocking FcαR1 (CD89)/IgA interaction using CD89 specific antibodies is a potential therapeutic target to resolve tissue damage in chronic inflammation and autoimmunity
van Delft - Soffers, M. A. M., Aleyd, E., van Egmond, M., van der Mast, R., Boon, L. & Simons, P. J., 2022.
Research output: Contribution to conference › Abstract › Academic
Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching
Bos, A. V., van Gool, M. M. J., Breedveld, A. C., van der Mast, R., Marsman, C., Bouma, G., van de Wiel, M. A., van Ham, S. M., Mebius, R. E. & van Egmond, M., 1 Oct 2022, In: International journal of molecular sciences. 23, 19, 18 p., 11132.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

2 Citations (Scopus)
2021

Nk cell-dependent antibody-mediated immunotherapy is improved in vitro and in vivo when combined with agonists for toll-like receptor 2 in head and neck cancer models
Gruijs, M., Ganzevles, S. H., Stigter-Van Walsum, M., van der Mast, R., van Ostaijen-Ten Dam, M. M., Tuk, C. W., Schilham, M. W., Leemans, C. R., Brakenhoff, R. H., van Egmond, M., van de Ven, R. & Bakema, J. E., 1 Oct 2021, In: International journal of molecular sciences. 22, 20, 11057.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

4 Citations (Scopus)
2019

Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death
van Harten, A. M., Buijze, M., van der Mast, R., Rooimans, M. A., Martens-de Kemp, S. R., Bachas, C., Brink, A., Stigter-van Walsum, M., Wolthuis, R. M. F. & Brakenhoff, R. H., 1 Jul 2019, In: Oncogenesis. 8, 7, 38.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

42 Citations (Scopus)